ArticleLasers in medical science2026
Confocal laser microendoscopy characterization of vascular features in facial basal cell carcinoma: a comparative analysis of tumor and adjacent healthy tissue.
Article in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
An initial application of Confocal laser microendoscopy (CLE) in basal cell carcinoma (BCC) was promising, yet data in this field are still limited. Tumor vasculature, which can be clearly visualized by CLE, differs significantly from that of normal tissue, but has not yet been systematically analyzed as a target of CLE in BCC. By systematically assessing vascular features, we aim to define diagnostic criteria that support a more standardized and objective use of CLE in BCC. CLE imaging was performed in nine patients with histologically confirmed facial BCC. Forty artifact-free vascular sequences (20 BCC, 20 healthy skin) were analyzed using five predefined criteria independently rated by three blinded reviewers. Diagnostic accuracy, sensitivity, specificity, and interrater agreement were calculated. Normal skin showed regular, well-defined, round vessels of uniform size, whereas BCC demonstrated heterogeneous, dilated, and elongated vessels with indistinct borders and variable flow. Mean sensitivity and specificity were 91.7 ± 4.7% and 86.7 ± 6.2%, respectively, with substantial interrater agreement (κ = 0.77). Vascular features in CLE sequences supported the differentiation between BCC and healthy skin. Incorporating vascular criteria into CLE-based scoring systems appears promising for a more standardized differentiation of BCC from healthy skin. Further studies with larger patient cohorts are warranted to validate these preliminary findings and assess their clinical applicability. Not applicable, as this study is a retrospective analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.